Abstract
Rectal cancer is currently a disease with great impact in the majority of countries. The selection of an effective course of treatment presents great difficulty in health care centers, especially due to genetic differences between patients that determine the outcome of a given treatment. Neoadjuvant chemoradiation has provided stimulating results in treatment of rectal cancer in spite of …